{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:31:06Z","timestamp":1767871866769,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,7]]},"DOI":"10.7759\/cureus.101050","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:37:47Z","timestamp":1767854267000},"source":"Crossref","is-referenced-by-count":0,"title":["Potential Therapeutic Synergy of High-Dose Vitamin C and Nicotinamide as Adjunctive Therapy in an Elderly Patient With Extensive-Stage Small-Cell Lung Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Minsu","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-ki","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Seok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je H","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt178","article-title":"Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24 Suppl 6","author":"Fr\u00fch M","year":"2013","unstructured":"Fr\u00fch M, De Ruysscher D, Popat S, Crin\u00f2 L, Peters S, Felip E. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013, 24 Suppl 6:vi99-105. 10.1093\/annonc\/mdt178","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26868","article-title":"Small cell lung cancer staging: prospective comparison of conventional staging tests, FDG PET\/CT, whole-body MRI, and coregistered FDG PET\/MRI","volume":"218","author":"Ohno Y","year":"2022","unstructured":"Ohno Y, Yoshikawa T, Takenaka D, et al.. Small cell lung cancer staging: prospective comparison of conventional staging tests, FDG PET\/CT, whole-body MRI, and coregistered FDG PET\/MRI. AJR Am J Roentgenol. 2022, 218:899-908. 10.2214\/AJR.21.26868","journal-title":"AJR Am J Roentgenol"},{"key":"ref3","unstructured":"Small Cell Lung Cancer. (2024). Accessed. January, 2025: http:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/SCLC-patient-guideline.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn L","year":"2018","unstructured":"Horn L, Mansfield AS, Szcz\u0119sna A, et al.. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018, 379:2220-9. 10.1056\/NEJMoa1809064","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares L","year":"2019","unstructured":"Paz-Ares L, Dvorkin M, Chen Y, et al.. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet. 2019, 394:1929-39. 10.1016\/S0140-6736(19)32222-6","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.772282","article-title":"Prophylactic cranial irradiation for extensive-stage small-cell lung cancer: a controversial area","volume":"12","author":"Xue S","year":"2022","unstructured":"Xue S, Zeng H, Yan S, Wang Q, Jia X. Prophylactic cranial irradiation for extensive-stage small-cell lung cancer: a controversial area. Front Oncol. 2022, 12:772282. 10.3389\/fonc.2022.772282","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.02.022","article-title":"Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme","volume":"17","author":"Avalos JL","year":"2005","unstructured":"Avalos JL, Bever KM, Wolberger C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell. 2005, 17:855-68. 10.1016\/j.molcel.2005.02.022","journal-title":"Mol Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/157591","article-title":"Role of nicotinamide in DNA damage, mutagenesis, and DNA repair","volume":"2010","author":"Surjana D","year":"2010","unstructured":"Surjana D, Halliday GM, Damian DL. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J Nucleic Acids. 2010, 2010:10.4061\/2010\/157591","journal-title":"J Nucleic Acids"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.12.079","article-title":"Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer","volume":"314","author":"Li QL","year":"2004","unstructured":"Li QL, Kim HR, Kim WJ, et al.. Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun. 2004, 314:223-8. 10.1016\/j.bbrc.2003.12.079","journal-title":"Biochem Biophys Res Commun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.02.017","article-title":"Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300","volume":"185","author":"Kim WJ","year":"2011","unstructured":"Kim WJ, Lee JW, Quan C, Youn HJ, Kim HM, Bae SC. Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300. J Urol. 2011, 185:2366-75. 10.1016\/j.juro.2011.02.017","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22799","article-title":"Nicotinamide inhibits the early stage of carcinogen-induced hepatocarcinogenesis in mice and suppresses human hepatocellular carcinoma cell growth","volume":"227","author":"Park SY","year":"2012","unstructured":"Park SY, Lee KB, Lee MJ, Bae SC, Jang JJ. Nicotinamide inhibits the early stage of carcinogen-induced hepatocarcinogenesis in mice and suppresses human hepatocellular carcinoma cell growth. J Cell Physiol. 2012, 227:899-908. 10.1002\/jcp.22799","journal-title":"J Cell Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-3059","article-title":"Nicotinamide in combination with EGFR-TKIs for the treatment of stage IV lung adenocarcinoma with EGFR mutations: a randomized double-blind (phase IIb) trial","volume":"30","author":"Oh HJ","year":"2024","unstructured":"Oh HJ, Bae SC, Oh IJ, et al.. Nicotinamide in combination with EGFR-TKIs for the treatment of stage IV lung adenocarcinoma with EGFR mutations: a randomized double-blind (phase IIb) trial. Clin Cancer Res. 2024, 30:1478-87. 10.1158\/1078-0432.CCR-23-3059","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-023-00257-0","article-title":"Long-term survival and stable disease in a patient with extensive-stage small-cell lung cancer after treatment with carboplatin, etoposide and atezolizumab","volume":"12","author":"Bernab\u00e9 R","year":"2024","unstructured":"Bernab\u00e9 R, Liu SV, S\u00e1nchez-Gastaldo A, Alonso Garc\u00eda M. Long-term survival and stable disease in a patient with extensive-stage small-cell lung cancer after treatment with carboplatin, etoposide and atezolizumab. Oncol Ther. 2024, 12:175-82. 10.1007\/s40487-023-00257-0","journal-title":"Oncol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31070271","article-title":"Durable response to atezolizumab in extensive-stage small-cell lung cancer leading to 60 months overall survival: a case report","volume":"31","author":"Paczkowski F","year":"2024","unstructured":"Paczkowski F, Raphael J, Browne C. Durable response to atezolizumab in extensive-stage small-cell lung cancer leading to 60 months overall survival: a case report. Curr Oncol. 2024, 31:3682-9. 10.3390\/curroncol31070271","journal-title":"Curr Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37757","article-title":"Prolonged survival in a patient with extensive-stage small-cell lung cancer in spite of discontinued immunotherapy with atezolizumab","volume":"15","author":"Konishi K","year":"2023","unstructured":"Konishi K, Kuwahara H, Morita D, Imai S, Nagata K. Prolonged survival in a patient with extensive-stage small-cell lung cancer in spite of discontinued immunotherapy with atezolizumab. Cureus. 2023, 15:e37757. 10.7759\/cureus.37757","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.09.006","article-title":"The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer","volume":"64","author":"Subedi N","year":"2009","unstructured":"Subedi N, Scarsbrook A, Darby M, Korde K, Mc Shane P, Muers MF. The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer. Lung Cancer. 2009, 64:301-7. 10.1016\/j.lungcan.2008.09.006","journal-title":"Lung Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446314-potential-therapeutic-synergy-of-high-dose-vitamin-c-and-nicotinamide-as-adjunctive-therapy-in-an-elderly-patient-with-extensive-stage-small-cell-lung-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:37:50Z","timestamp":1767854270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446314-potential-therapeutic-synergy-of-high-dose-vitamin-c-and-nicotinamide-as-adjunctive-therapy-in-an-elderly-patient-with-extensive-stage-small-cell-lung-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.101050","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}